Documents
Application Sponsors
NDA 020430 | ASPEN GLOBAL INC | |
Marketing Status
Application Products
001 | INJECTABLE;INJECTION | 750 UNITS/0.6ML | 0 | ORGARAN | DANAPAROID SODIUM |
FDA Submissions
TYPE 1; Type 1 - New Molecular Entity | ORIG | 1 | AP | 1996-12-24 | STANDARD |
LABELING; Labeling | SUPPL | 2 | AP | 1998-01-30 | STANDARD |
EFFICACY; Efficacy | SUPPL | 3 | AP | 2001-06-26 | STANDARD |
Submissions Property Types
CDER Filings
ASPEN GLOBAL INC
cder:Array
(
[0] => Array
(
[ApplNo] => 20430
[companyName] => ASPEN GLOBAL INC
[docInserts] => ["",""]
[products] => [{"drugName":"ORGARAN","activeIngredients":"DANAPAROID SODIUM","strength":"750 UNITS\/0.6ML","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
[labels] => [{"actionDate":"06\/26\/2001","submission":"SUPPL-3","supplementCategories":"Efficacy-Labeling Change With Clinical Data","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/nda\\\/2001\\\/20-430S003_Orgaran_prntlbl.pdf\"}]","notes":""}]
[originalApprovals] => [{"actionDate":"ORGARAN","submission":"DANAPAROID SODIUM","actionType":"750 UNITS\/0.6ML","submissionClassification":"INJECTABLE;INJECTION","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
[supplements] =>
[actionDate] => 2001-06-26
)
)